World's Best Scientists 2026 revealed!

D-Index & Metrics

Microbiology

D-Index
52
Citations
9179
World Ranking
4222
National Ranking
24

Overview

Yoram Reiter is affiliated with the Technion - Israel Institute of Technology in Israel. Their research primarily spans fields including Medicine and Immunology and Microbiology, with a strong focus on subfields such as Immunology, Oncology, Infectious Diseases, Molecular Biology, and Biomedical Engineering.

The scientist's work concentrates heavily on topics related to CAR-T cell therapy research, immunotherapy and immune responses, and immune cell function and interaction. Other notable subjects of their research include T-cell and B-cell immunology, SARS-CoV-2 and COVID-19 research, COVID-19 clinical research studies, and viral infectious diseases and gene expression in insects.

Among recent publications by Yoram Reiter are:

  • Serologic Status and Toxic Effects of the SARS-CoV-2 BNT162b2 Vaccine in Patients Undergoing Treatment for Cancer, 2021, JAMA Oncology
  • Multi-center nationwide comparison of seven serology assays reveals a SARS-CoV-2 non-responding seronegative subpopulation, 2020, EClinicalMedicine
  • Shaping Functional Avidity of CAR T Cells: Affinity, Avidity, and Antigen Density That Regulate Response, 2021, Molecular Cancer Therapeutics
  • Phenotypic Models of CAR T-Cell Activation Elucidate the Pivotal Regulatory Role of CAR Downmodulation, 2021, Molecular Cancer Therapeutics
  • The Intracellular Proteome as a Source for Novel Targets in CAR-T and T-Cell Engagers-Based Immunotherapy, 2022, Cells

Frequent co-authors in Yoram Reiter's research include Maya Haus-Cohen, Efrat Altman, Inbar Arman, Raanan Greenman, and Yoav Pizem.

Regular venues for their work include Molecular Cancer Therapeutics, bioRxiv (Cold Spring Harbor Laboratory), JAMA Oncology, EClinicalMedicine, and Cells. Molecular Cancer Therapeutics and bioRxiv each contain multiple publications by this scientist.

Best Publications

  • Functional Specializations of Human Epidermal Langerhans Cells and CD14+ Dermal Dendritic Cells

    Eynav Klechevsky;Eynav Klechevsky;Rimpei Morita;Maochang Liu;Yanying Cao

  • Recombinant antibodies with MHC-restricted, peptide-specific, T-cell receptor-like specificity: new tools to study antigen presentation and TCR-peptide-MHC interactions.

    Cyril J. Cohen;Galit Denkberg;Avital Lev;Malka Epel

  • Selective Targeting of Melanoma and APCs Using a Recombinant Antibody with TCR-Like Specificity Directed Toward a Melanoma Differentiation Antigen

    Galit Denkberg;Avital Lev;Lea Eisenbach;Itai Benhar

  • A recombinant immunotoxin containing a disulfide-stabilized Fv fragment

    U. Brinkmann;Y. Reiter;Sun-Hee Jung;Byungkook Lee

  • Engineering antibody Fv fragments for cancer detection and therapy: disulfide-stabilized Fv fragments.

    Yoram Reiter;Ulrich Brinkmann;Byungkook Lee;Ira Pastan

  • Engineering interchain disulfide bonds into conserved framework regions of Fv fragments: improved biochemical characteristics of recombinant immunotoxins containing disulfide-stabilized Fv.

    Yoram Reiter;Ulrich Brinkmann;Keith O. Webber;Sun-Hee Jung

  • Stabilization of the Fv fragments in recombinant immunotoxins by disulfide bonds engineered into conserved framework regions

    Yoram Reiter;Ulrich Brinkmann;Robert J. Kreitman;Sun-Hee Jung

  • The length of lipids bound to human CD1d molecules modulates the affinity of NKT cell TCR and the threshold of NKT cell activation

    C McCarthy;D Shepherd;S Fleire;V S Stronge

  • Cross-priming CD8+ T cells by targeting antigens to human dendritic cells through DCIR

    Eynav Klechevsky;Eynav Klechevsky;Anne-Laure Flamar;Anne-Laure Flamar;Yanying Cao;Jean-Philippe Blanck

  • A Novel Host-Proteome Signature for Distinguishing between Acute Bacterial and Viral Infections

    Kfir Oved;Asi Cohen;Olga Boico;Roy Navon

  • An antibody single-domain phage display library of a native heavy chain variable region: isolation of functional single-domain VH molecules with a unique interface.

    Yoram Reiter;Peter Schuck;Lisa F Boyd;Daniel Plaksin

  • Recombinant Fv immunotoxins and Fv fragments as novel agents for cancer therapy and diagnosis

    Yoram Reiter;Ira Pastan

  • Improved binding and antitumor activity of a recombinant anti-erbB2 immunotoxin by disulfide stabilization of the Fv fragment.

    Y. Reiter;U. Brinkmann;Sun-Hee Jung;Byungkook Lee

  • Isolation and Characterization of Human Recombinant Antibodies Endowed with the Antigen-specific, Major Histocompatibility Complex-restricted Specificity of T Cells Directed toward the Widely Expressed Tumor T-cell Epitopes of the Telomerase Catalytic Subunit

    Avital Lev;Galit Denkberg;Cyril J Cohen;Maty Tzukerman

  • Functional Comparison of Engineered T Cells Carrying a Native TCR versus TCR-like Antibody–Based Chimeric Antigen Receptors Indicates Affinity/Avidity Thresholds

    Ravit Oren;Moran Hod-Marco;Maya Haus-Cohen;Sharyn Thomas

  • Direct visualization of distinct T cell epitopes derived from a melanoma tumor-associated antigen by using human recombinant antibodies with MHC- restricted T cell receptor-like specificity.

    Galit Denkberg;Cyril J. Cohen;Avital Lev;Patrick Chames

  • Mhc-peptide complex binding ligands

    Henricus Renerus Jacobus Mattheus Hoogenboom;Yoram Reiter

  • Increased expression of human T lymphocyte virus type I (HTLV-I) Tax11-19 peptide-human histocompatibility leukocyte antigen A*201 complexes on CD4+ CD25+ T Cells detected by peptide-specific, major histocompatibility complex-restricted antibodies in patients with HTLV-I-associated neurologic disease.

    Yoshihisa Yamano;Cyril J. Cohen;Norihiro Takenouchi;Karen Yao

  • Serologic Status and Toxic Effects of the SARS-CoV-2 BNT162b2 Vaccine in Patients Undergoing Treatment for Cancer.

    Tal Goshen-Lago;Ithai Waldhorn;Roy Holland;Moran Szwarcwort-Cohen

  • Multi-center nationwide comparison of seven serology assays reveals a SARS-CoV-2 non-responding seronegative subpopulation.

    Kfir Oved;Liraz Olmer;Yonat Shemer-Avni;Tamar Wolf

  • Direct Phenotypic Analysis of Human MHC Class I Antigen Presentation: Visualization, Quantitation, and In Situ Detection of Human Viral Epitopes Using Peptide-Specific, MHC-Restricted Human Recombinant Antibodies

    Cyril J. Cohen;Offra Sarig;Yoshihisa Yamano;Utano Tomaru

Frequent Co-Authors

Ira Pastan
Ira Pastan Center for Cancer Research
Itai Benhar
Itai Benhar Tel Aviv University
Halina Offner
Halina Offner Oregon Health & Science University
Jay A. Berzofsky
Jay A. Berzofsky National Institutes of Health
Zelig Eshhar
Zelig Eshhar Weizmann Institute of Science
Masaki Terabe
Masaki Terabe National Institutes of Health
Donald Kufe
Donald Kufe Harvard University
Yehuda G. Assaraf
Yehuda G. Assaraf Technion – Israel Institute of Technology
Richard Stone
Richard Stone Harvard University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Studying Microbiology in the USA opens doors to diverse career options, including roles in health information management and medical coding. For students interested in administrative and data management within healthcare, pursuing an online cahiim accredited health information management degree offers a robust pathway. These programs equip graduates with skills to handle patient data, comply with regulations, and improve healthcare operations.

Meanwhile, those interested in the coding side of healthcare billing might consider exploring the best fastest online medical billing and coding certificate programs. These certificates can quickly prepare you for certification and entry-level positions in the field.

Certified professional coders earn competitive pay, with many resources highlighting the cpc salary, making it an attractive option for microbiology graduates looking to diversify their expertise beyond the lab.

Additionally, a career as a health information manager is another lucrative path for microbiology students, who can leverage their scientific background in managing healthcare data. Insight into the health information management salary reveals strong earning potential and growth prospects in this sector.

Best Scientists Citing Yoram Reiter

Trending Scientists